Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan

Article Figures & Data

Table 1

Participants’ characteristics. n= 694

Variables	n (%)
Gender
Male	388 (55.9)
Female	306 (44.1)
Age, years, mean ± SD	8.6±4.5
Age groups
<1 year	28 (4.0)
1 to <6 years	229 (33.0)
6 years to <12 years	289 (41.6)
12 years to 18 years	148 (21.3)
Distribution of patients by centers
Educational	478 (68.9)
Governmental	216 (31.1)

Table 2

Frequency of initial therapy in monotherapy and combination therapy in 696 patients.

Table 3

Frequency of antiepileptic monotherapy and dual combinations.

Monotherapy n= 465	n (%)	Dual therapy combinations n=162	n (%)
Valproic acid	235 (50.5)	Valproic acid+Carbamazepine	28 (17.3)
Carbamazepine	155 (33.3)	Carbamazepine+Levetiracetam	21 (13)
Levetiracetam	19 (4.1)	Valproic acid+Levetiracetam	20 (12.3)
Phenobarbitone	17 (3.7)	Valproic acid+Topiramate	16 (9.9)
Topiramate	16 (3.4)	Valproic acid+Phenobarbitone	12 (7.4)
Lamotrigine	12 (2.6)	Valproic acid+Clonazepam	12 (7.4)
Oxcarbazepine	5 (1.1)	Valproic acid+Lamotrigine	9 (5.6)
Others	11 (1.3)	Others	44 (27.1)